Form 4: Adaptimmune Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4
John Lunger, Chief Patient Supply Officer of Adaptimmune Therapeutics PLC, sold American Depositary Shares (ADS) to cover tax obligations related to the exercise of vested RSU-style share options.
Summary
- John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics PLC, filed a Form 4 detailing the sale of American Depositary Shares (ADS).
- The sales occurred on January 13, 2025, and January 15, 2025, at weighted average prices ranging from $0.5748 to $0.5879 per ADS.
- These transactions were part of a 'Sell to Cover' exercise, where shares were sold to satisfy tax withholding obligations and associated sale costs related to the vesting and exercise of RSU-style share options.
- The ADSs represent ordinary shares of Adaptimmune Therapeutics PLC, with each ADS representing six ordinary shares.
- Lunger still holds 136,156 ADSs and RSU-style options and other options covering an aggregate of 10,214,526 ordinary shares of the Issuer.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation and tax obligations, with no indication of positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence, often related to compensation and tax planning. The 'Sell to Cover' mechanism is a standard practice to manage tax obligations associated with equity compensation.
Key Dates
| Date | Description |
|---|---|
| 01/11/2021 | Date of grant of RSU-style share option, approximately 25% of which was exercised. |
| 01/12/2022 | Date of grant of RSU-style share option, approximately 25% of which was exercised. |
| 01/15/2024 | Date of grant of RSU-style share option, approximately 25% of which was exercised. |
| 01/13/2025 | Date of ADS sale to cover tax obligations. |
| 01/15/2025 | Date of ADS sale to cover tax obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.